Immunohistochemical staining of IPMN nodules, a high-risk feature, and an indication for surgical resection, also revealed significantly increased expression of SLC2A1/GLUT1 glucose transporter in samples consistent with advanced neoplasia when compared to low-grade dysplasia. Here, SLC2A1 is linked to pancreatic intraductal papillary-mucinous neoplasm.